Functional connectivity in autosomal dominant and late-onset Alzheimer disease.

PubWeight™: 2.28‹?› | Rank: Top 2%

🔗 View Article (PMC 4240274)

Published in JAMA Neurol on September 01, 2014

Authors

Jewell B Thomas1, Matthew R Brier1, Randall J Bateman1, Abraham Z Snyder2, Tammie L Benzinger2, Chengjie Xiong3, Marcus Raichle4, David M Holtzman1, Reisa A Sperling5, Richard Mayeux6, Bernardino Ghetti7, John M Ringman8, Stephen Salloway9, Eric McDade10, Martin N Rossor11, Sebastien Ourselin11, Peter R Schofield12, Colin L Masters13, Ralph N Martins14, Michael W Weiner15, Paul M Thompson16, Nick C Fox17, Robert A Koeppe18, Clifford R Jack19, Chester A Mathis20, Angela Oliver1, Tyler M Blazey2, Krista Moulder21, Virginia Buckles1, Russ Hornbeck2, Jasmeer Chhatwal22, Aaron P Schultz22, Alison M Goate23, Anne M Fagan1, Nigel J Cairns1, Daniel S Marcus2, John C Morris1, Beau M Ances1

Author Affiliations

1: Department of Neurology, Washington University in St Louis, St Louis, Missouri.
2: Department of Radiology, Washington University in St Louis, St Louis, Missouri.
3: Division of Biostatistics, Washington University in St Louis, St Louis, Missouri.
4: Department of Neurology, Washington University in St Louis, St Louis, Missouri2Department of Radiology, Washington University in St Louis, St Louis, Missouri4Department of Anatomy and Neurobiology, Washington University in St Louis, St Louis, Missouri.
5: Department of Neurology, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston.
6: Department of Neurology, Columbia University Medical Center, New York, New York.
7: Department of Pathology and Laboratory Medicine, Indiana University, Bloomington.
8: Department of Neurology, Easton Center for Alzheimer's Disease Research, David Geffen School of Medicine, University of California, Los Angeles.
9: Departments of Neurology and Psychiatry, Warren Alpert Medical School, Brown University, Providence, Rhode Island.
10: Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania.
11: Dementia Research Centre, Institute of Neurology, University College London, London, England.
12: Neuroscience Research Australia, Sydney, Australia13School of Medical Sciences, University of New South Wales, Sydney, Australia.
13: Mental Health Research Institute, University of Melbourne, Melbourne, Australia.
14: School of Medical Sciences, Edith Cowan University, Joondalup, Australia.
15: Department of Medicine, University of California, San Francisco17Department of Radiology, University of California, San Francisco18Department of Psychiatry, University of California, San Francisco.
16: Departments of Neurology and Psychiatry, Imaging Genetics Center, Laboratory of Neuroimaging, David Geffen School of Medicine at University of California, Los Angeles.
17: Dementia Research Centre, Department of Neurodegeneration, Institute of Neurology, University College of London, London, England.
18: Department of Radiology, University of Michigan, Ann Arbor.
19: Department of Radiology, Mayo Clinic, Rochester, Minnesota.
20: Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
21: Department of Psychiatry, Washington University in St Louis, St Louis, Missouri.
22: Department of Neurology, Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston.
23: Department of Psychiatry, University of California, San Francisco.

Articles citing this

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain (2016) 1.51

The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron (2014) 1.35

Aberrant intra- and inter-network connectivity architectures in Alzheimer's disease and mild cognitive impairment. Sci Rep (2015) 0.89

Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Hum Brain Mapp (2015) 0.88

Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study. JAMA Neurol (2015) 0.85

An Eye on Brain Integrity: Acute Optic Neuritis Affects Resting State Functional Connectivity. Invest Ophthalmol Vis Sci (2015) 0.83

Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J Nucl Med (2014) 0.82

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci (2017) 0.82

NPTX2 and cognitive dysfunction in Alzheimer's Disease. Elife (2017) 0.81

Clinical exome sequencing in neurogenetic and neuropsychiatric disorders. Ann N Y Acad Sci (2015) 0.81

Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res (2016) 0.79

Aberrant Insular Functional Network Integrity in Patients with Obstructive Sleep Apnea. Sleep (2016) 0.78

The Structural and Functional Connectome and Prediction of Risk for Cognitive Impairment in Older Adults. Curr Behav Neurosci Rep (2015) 0.77

Disrupted functional brain network organization in patients with obstructive sleep apnea. Brain Behav (2016) 0.76

Cognitive complaints in older adults at risk for Alzheimer's disease are associated with altered resting-state networks. Alzheimers Dement (Amst) (2016) 0.76

Early Cerebellar Network Shifting in Spinocerebellar Ataxia Type 6. Cereb Cortex (2015) 0.76

Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI. Neuroimage Clin (2017) 0.76

The value of biomarker comparisons between autosomal dominant and late-onset Alzheimer disease. JAMA Neurol (2014) 0.76

Altered Intranetwork and Internetwork Functional Connectivity in Type 2 Diabetes Mellitus With and Without Cognitive Impairment. Sci Rep (2016) 0.76

Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Sci Rep (2016) 0.75

Alzheimer disease: Functional connectivity changes show similar trajectories in autosomal dominant and sporadic Alzheimer disease. Nat Rev Neurol (2014) 0.75

Resting-state network dysfunction in Alzheimer's disease: A systematic review and meta-analysis. Alzheimers Dement (Amst) (2017) 0.75

Articles cited by this

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59

The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72

Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med (1995) 42.32

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56

Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage (2011) 19.70

Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci (2007) 19.58

Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22

Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci (2005) 12.85

The impact of global signal regression on resting state correlations: are anti-correlated networks introduced? Neuroimage (2008) 10.96

Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI. Neuroimage (2006) 10.95

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol (2006) 9.99

The global signal and observed anticorrelated resting state brain networks. J Neurophysiol (2009) 9.64

Alzheimer's disease. Lancet (2006) 9.15

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04

Default-mode activity during a passive sensory task: uncoupled from deactivation but impacting activation. J Cogn Neurosci (2004) 7.29

Neural basis of global resting-state fMRI activity. Proc Natl Acad Sci U S A (2010) 4.25

Methods to detect, characterize, and remove motion artifact in resting state fMRI. Neuroimage (2013) 3.86

Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry (2009) 3.72

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol (2011) 3.69

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol (2012) 3.48

Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann Neurol (2003) 2.72

Right hemisphere dominance during spatial selective attention and target detection occurs outside the dorsal frontoparietal network. J Neurosci (2010) 2.67

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. Lancet Neurol (2012) 2.65

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther (2011) 2.51

Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem (2012) 2.42

Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol (2011) 2.40

Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet (2011) 2.26

Loss of intranetwork and internetwork resting state functional connections with Alzheimer's disease progression. J Neurosci (2012) 2.26

The nuisance of nuisance regression: spectral misspecification in a common approach to resting-state fMRI preprocessing reintroduces noise and obscures functional connectivity. Neuroimage (2013) 1.75

Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging. Behav Neurol (2009) 1.58

Neurophysiological investigation of spontaneous correlated and anticorrelated fluctuations of the BOLD signal. J Neurosci (2013) 1.47

High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol (2009) 1.45

Dominantly Inherited Alzheimer Network: facilitating research and clinical trials. Alzheimers Res Ther (2013) 1.44

Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol (2012) 1.44

Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol (2009) 1.22

Correlating familial Alzheimer's disease gene mutations with clinical phenotype. Biomark Med (2010) 1.21

Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology (2013) 1.16

Harmonized diagnostic criteria for Alzheimer's disease: recommendations. J Intern Med (2014) 1.07

Cerebrospinal fluid biomarkers of Alzheimer's disease. Biomark Med (2010) 1.03

Alzheimer disease family history impacts resting state functional connectivity. Ann Neurol (2012) 0.97

Differences in regional brain atrophy in genetic forms of Alzheimer's disease. Neurobiol Aging (2006) 0.94

Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease. Curr Alzheimer Res (2009) 0.91

Articles by these authors

Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol (2016) 1.76

Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene. JAMA Neurol (2013) 1.16

Association of lifetime intellectual enrichment with cognitive decline in the older population. JAMA Neurol (2014) 1.04

Emerging β-amyloid pathology and accelerated cortical atrophy. JAMA Neurol (2014) 0.93

Rich club analysis in the Alzheimer's disease connectome reveals a relatively undisturbed structural core network. Hum Brain Mapp (2015) 0.87

Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals. JAMA Neurol (2015) 0.83

White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration. JAMA Neurol (2014) 0.80

Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. J Gerontol A Biol Sci Med Sci (2014) 0.78

3D tract-specific local and global analysis of white matter integrity in Alzheimer's disease. Hum Brain Mapp (2016) 0.76

Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging. J Am Geriatr Soc (2016) 0.76

Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging. JAMA Neurol (2017) 0.76

Association Between Microinfarcts and Blood Pressure Trajectories. JAMA Neurol (2017) 0.75

Brain Atrophy on Magnetic Resonance Imaging as a Biomarker of Neurodegeneration. JAMA Neurol (2016) 0.75

Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia. JAMA Neurol (2017) 0.75

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging. JAMA Neurol (2017) 0.75